JP Morgan Reiterates Buy Rating on JBS
JP Morgan maintains its buy rating on JBS, setting an $18 price target, a 47.30% upside from the current price.
Key Points
- JP Morgan reiterated its buy rating on JBS, setting a price target of $18 on June 29, 2026.
- JP Morgan's $18 price target implies 47.30% upside from JBS N.V.'s ($JBS) current $12.22 share price.
- Shares of JBS traded near $12.22 on Monday, reflecting the latest analyst action.
- Several funds adjusted their positions in JBS, including BlackRock and Davis Selected Advisers.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
JP Morgan has reiterated its buy rating for JBS, setting a price target of $18. This action, taken on June 29, 2026, reflects the firm's continued confidence in the company's prospects.
JP Morgan vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in JBS
Several institutional investors have been active in JBS. BlackRock, Inc. increased its holdings by 3,284,423 shares, bringing its total to 28,826,636 shares valued at approximately $517.7 million, marking a 12.9% increase. Davis Selected Advisers significantly boosted its position by 14,389,919 shares to a total of 26,244,660 shares, worth about $471.4 million, which is a 121.4% rise. Arrowstreet Capital, Limited Partnership also expanded its stake by 4,147,304 shares, resulting in 7,687,775 shares valued at $138.1 million, reflecting a 117.1% increase. In contrast, Ameriprise Financial Inc trimmed its position by 136,124 shares, ending with 6,704,692 shares valued at $120.4 million, a 2% decrease.
JBS N.V. Stock Down 10.1%
Shares of JBS traded near $12.22 on Monday. The stock has seen various institutional activities that could influence its future movements. Investors are closely watching how these changes, along with analyst ratings, might impact the stock's performance.
$JBS price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at JBS N.V.
Several insiders have been buying shares of JBS. Guilherme Perboyre Cavalcanti, the Global CFO and IRO, acquired 112,098 shares on June 9, 2026, and 185,828 shares on May 21, 2026. Additionally, Jeremiah Alphonsus O'Callaghan purchased 76,782 shares on May 21, 2026. These transactions suggest confidence from the company's leadership.
Analysts Set New Price Targets
On June 29, 2026, JP Morgan maintained its buy rating on JBS with a price target of $18. This was part of a broader trend where JP Morgan has consistently supported the stock with a buy rating over recent months. Barclays also maintained a buy rating on JBS with a higher price target of $21 on May 14, 2026.
Bottom Line
JP Morgan's reiterated buy rating and $18 price target highlight confidence in JBS's potential. Institutional moves, such as those by BlackRock and Davis Selected Advisers, further underscore interest in the stock. As always, remember that analyst ratings and institutional filings like these are backward-looking and should be considered as part of a broader investment strategy.
Get JBS N.V. alerts
New 13F filings, insider trades, and analyst moves on $JBS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.